Humana (HUM)
(Delayed Data from NYSE)
$260.71 USD
+2.88 (1.12%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $260.81 +0.10 (0.04%) 7:58 PM ET
3-Hold of 5 3
A Value B Growth D Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$260.71 USD
+2.88 (1.12%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $260.81 +0.10 (0.04%) 7:58 PM ET
3-Hold of 5 3
A Value B Growth D Momentum A VGM
Zacks News
Can a Divided Congress Boost Healthcare Stocks? 4 Picks
by Zacks Equity Research
A divided Congress ensures Obamacare stays in place.
Top Ranked Growth Stocks to Buy for December 12th
by Zacks Equity Research
Here are three stocks with buy ranks and strong growth characteristics for investors to consider today, December 12th:
Moody's Downgrades Acadia's (ACHC) Outlook, Affirms Ratings
by Zacks Equity Research
Acadia Healthcare (ACHC) receives rating actions from Moody's. Outlook down to negative from stable.
Top Ranked Growth Stocks to Buy for December 10th
by Zacks Equity Research
Here are three stocks with buy ranks and strong growth characteristics for investors to consider today, December 10th:
Humana (HUM) Down 6.9% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Humana (HUM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Top Ranked Growth Stocks to Buy for December 7th
by Zacks Equity Research
Here are three stocks with buy ranks and strong growth characteristics for investors to consider today, December 7th
WellCare (WCG) Buys Aetna's Medicare Assets to Fuel Growth
by Zacks Equity Research
WellCare's (WCG) purchase of Medicare business of Aetna should lead to long-term growth.
Near-Term Outlook for Medical Information Systems Industry
by Zacks Equity Research
The wave of digital transition is helping companies in the Zacks Medical Info Systems industry to create opportunities for investors.
HMO Industry Surges Almost 4 Times S&P 500: 4 Picks
by Sapna Bagaria
Health insurers gains on strong industry and operating conditions, the same should continue in 2019.
PRA Health Sciences (PRAH) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
PRA Health Sciences (PRAH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
HCA (HCA) Hits 52-Week High, Can the Run Continue?
by Zacks Equity Research
HCA (HCA) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
BioTelemetry (BEAT) Soars to 52-Week High, Time to Cash Out?
by Zacks Equity Research
BioTelemetry (BEAT) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Humana to Gain from Share Buyback, Raise Membership Outlook
by Zacks Equity Research
Humana (HUM) announces accelerated share buyback and gears up for increased Medicare Advantage membership.
6 Reasons Why You Should Add Anthem Stock to Your Portfolio
by Zacks Equity Research
Riding high on robust results, strong capital efficiency and buyouts; Anthem (ANTM) holds great prospects to reap returns for investors.
UnitedHealth Gains on Strong 2019 Outlook, Acquisition News
by Zacks Equity Research
UnitedHealth's (UNH) strong 2019 guidance boosts investors' confidence in it.
Here's Why Humana (HUM) Stock Looks Attractive Right Now
by Zacks Equity Research
Favorable changes across the industry and Humana's (HUM) strong operating profitability poise it for solid growth.
New Trends in Healthcare Push Stocks Higher: 5 Picks
by Zacks Equity Research
New healthcare trends backed by split party control of Congress are likely to boost industry stocks.
Humana Sees Hammer Chart Pattern: Time to Buy?
by Zacks Equity Research
Humana has been struggling lately, but the selling pressure may be coming to an end soon.
Humana, PIP Collaborate on Better HealthCare for MA Members
by Zacks Equity Research
Humana (HUM) enters into an agreement with Premier Independent Physicians to provide Medicare Advantage Members in Dallas-Fort Worth Metro with a better patient experience.
Here's What Makes Molina Healthcare (MOH) an Attractive Bet
by Zacks Equity Research
Favorable changes across the industry and inside the company poise Molina Healthcare (MOH) for strong growth.
Near-Term Outlook for Health Maintenance Organization Industry
by Zacks Equity Research
Retiring baby boomer population, new streams of revenues and consolidation paint a bright picture for the HMO industry.
Dollar Surges to 16-Month High: 5 Domestic Picks
by Swarup Gupta
The dollar's surge and a strong U.S. economy would make domestically focused stocks better options
The Zacks Analyst Blog Highlights: Altria, American Express, U.S. Bancorp, T-Mobile and Humana
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Altria, American Express, U.S. Bancorp, T-Mobile and Humana
Top Stock Reports for Altria, American Express & U.S. Bancorp
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Altria (MO), American Express (AXP) and U.S. Bancorp (USB).
The Zacks Analyst Blog Highlights: UnitedHealth Group, Anthem and Humana
by Zacks Equity Research
The Zacks Analyst Blog Highlights: UnitedHealth Group, Anthem and Humana